Financial Ratios Star Health and Allied Insurance Company Limited
Equities
STARHEALTH
INE575P01011
Life & Health Insurance
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 445.15 INR | -0.90% |
|
-0.56% | -2.16% |
| Dec. 18 | Star Health insurance gets tax penalty of 5.3 million rupees | RE |
| 25-10-30 | JM Financial Upgrades Star Health and Allied Insurance Company to Add from Hold; Price Target is INR525 | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -7.31 | -6.38 | 3.62 | 4.39 | 2.98 | |||||
Return on Total Capital | -19.92 | -14.6 | 8.07 | 10.6 | 7.83 | |||||
Return On Equity % | -28.16 | -19.61 | 9.53 | 12.69 | 9.33 | |||||
Return on Common Equity | -28.16 | -19.61 | 9.53 | 12.69 | 9.33 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 8.71 | 5.12 | 25.36 | 25.21 | 21.18 | |||||
SG&A Margin | 26.69 | 17.85 | 17.79 | 16.59 | 15.43 | |||||
EBITDA Margin % | -18.35 | -12.59 | 7.73 | 8.78 | 5.94 | |||||
EBITA Margin % | -18.62 | -12.76 | 7.56 | 8.62 | 5.75 | |||||
EBIT Margin % | -18.62 | -12.76 | 7.56 | 8.62 | 5.75 | |||||
Income From Continuing Operations Margin % | -15.16 | -9.81 | 5.11 | 6.03 | 4.01 | |||||
Net Income Margin % | -15.16 | -9.81 | 5.11 | 6.03 | 4.01 | |||||
Net Avail. For Common Margin % | -15.16 | -9.81 | 5.11 | 6.03 | 4.01 | |||||
Normalized Net Income Margin | -11.96 | -8.22 | 4.27 | 5.03 | 3.34 | |||||
Levered Free Cash Flow Margin | -11.58 | -11.73 | 3.82 | -0.36 | 8.23 | |||||
Unlevered Free Cash Flow Margin | -11.25 | -11.45 | 4.28 | -0 | 8.48 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.63 | 0.8 | 0.76 | 0.82 | 0.83 | |||||
Fixed Assets Turnover | 80.7 | 157.75 | 182.24 | 152.29 | 131.83 | |||||
Receivables Turnover (Average Receivables) | 36.62 | 68.41 | 46.16 | 32.91 | 21.27 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.35 | 1.62 | 1.58 | 1.81 | 0.47 | |||||
Quick Ratio | 1.65 | 1.41 | 1.35 | 1.53 | 0.42 | |||||
Operating Cash Flow to Current Liabilities | 0.57 | 0.03 | 0.63 | 0.53 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 9.97 | 5.33 | 7.91 | 11.12 | 17.16 | |||||
Average Days Payable Outstanding | 69.39 | 45.08 | 52.71 | 46.04 | 47.51 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 5.93 | 11.26 | 7.13 | 6.98 | 6.61 | |||||
Total Debt / Total Capital | 5.6 | 10.12 | 6.66 | 6.53 | 6.2 | |||||
LT Debt/Equity | 5.93 | 11.26 | 7.13 | 6.98 | 6.61 | |||||
Long-Term Debt / Total Capital | 5.6 | 10.12 | 6.66 | 6.53 | 6.2 | |||||
Total Liabilities / Total Assets | 62.44 | 58.14 | 59.72 | 62.71 | 65.78 | |||||
EBIT / Interest Expense | -35.76 | -27.95 | 10.35 | 15.09 | 14.15 | |||||
EBITDA / Interest Expense | -35.24 | -27.58 | 10.57 | 15.37 | 14.63 | |||||
(EBITDA - Capex) / Interest Expense | -36.86 | -28.89 | 10.05 | 13.83 | 13.36 | |||||
Total Debt / EBITDA | -0.25 | -0.54 | 0.5 | 0.38 | 0.49 | |||||
Net Debt / EBITDA | 1.63 | -0.12 | 0.17 | 0.02 | -0.21 | |||||
Total Debt / (EBITDA - Capex) | -0.24 | -0.52 | 0.53 | 0.42 | 0.54 | |||||
Net Debt / (EBITDA - Capex) | 1.56 | -0.11 | 0.18 | 0.02 | -0.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 9.44 | 109.94 | 14.11 | 15.9 | 14.87 | |||||
Gross Profit, 1 Yr. Growth % | -68.92 | 613.17 | 465.68 | 15.25 | -3.52 | |||||
EBITDA, 1 Yr. Growth % | -319.24 | -2.47 | -172.71 | 27.38 | -24.54 | |||||
EBITA, 1 Yr. Growth % | -329.61 | -4.35 | -168.85 | 32.12 | -23.44 | |||||
EBIT, 1 Yr. Growth % | -329.61 | -4.35 | -168.85 | 32.12 | -23.44 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -408.05 | -4.15 | -159.44 | 36.6 | -23.57 | |||||
Net Income, 1 Yr. Growth % | -408.05 | -4.15 | -159.44 | 36.6 | -23.57 | |||||
Normalized Net Income, 1 Yr. Growth % | -352.29 | -3.28 | -159.25 | 36.58 | -23.68 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -401.82 | -14.25 | -155.82 | 36.31 | -23.47 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 8.51 | -8.63 | 6.89 | 68.46 | 11.46 | |||||
Accounts Receivable, 1 Yr. Growth % | -48.18 | 100.73 | 57.05 | 64.74 | 82.07 | |||||
Total Assets, 1 Yr. Growth % | 83.22 | 36.11 | 7.06 | 10.37 | 15.12 | |||||
Common Equity, 1 Yr. Growth % | 156.05 | 51.69 | 3.02 | 2.17 | 5.65 | |||||
Tangible Book Value, 1 Yr. Growth % | 160.17 | 51.46 | 3.2 | 1.93 | 5.75 | |||||
Cash From Operations, 1 Yr. Growth % | 37.53 | -93.76 | 2.2K | 2.68 | 5.24 | |||||
Capital Expenditures, 1 Yr. Growth % | 36.66 | 36.98 | -26.2 | 165.05 | -33.02 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 252.82 | 41.46 | -137.14 | -110.87 | -84.05 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 280.7 | 40.86 | -143.15 | -100.03 | -83.66 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 20.27 | 45.96 | 54.78 | 15.01 | 15.39 | |||||
Gross Profit, 2 Yr. CAGR % | -36.71 | -40.38 | 535.16 | 155.33 | 5.46 | |||||
EBITDA, 2 Yr. CAGR % | 109.31 | 71.09 | -17.35 | -2.11 | -0.53 | |||||
EBITA, 2 Yr. CAGR % | 118.21 | 74.98 | -19.56 | -4.62 | 0.59 | |||||
EBIT, 2 Yr. CAGR % | 118.21 | 74.98 | -19.56 | -4.62 | 0.59 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 153.74 | 97.05 | -24.52 | -9.89 | 2.18 | |||||
Net Income, 2 Yr. CAGR % | 153.74 | 97.05 | -24.52 | -9.89 | 2.18 | |||||
Normalized Net Income, 2 Yr. CAGR % | 139.2 | 83.74 | -24.3 | -10.05 | 2.09 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 143.92 | 84.48 | -30.82 | -12.77 | 2.14 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.3 | -0.43 | -1.17 | 34.19 | 37.03 | |||||
Accounts Receivable, 2 Yr. CAGR % | 71.96 | 1.99 | 77.56 | 60.85 | 73.19 | |||||
Total Assets, 2 Yr. CAGR % | 49.29 | 57.92 | 20.71 | 8.7 | 12.72 | |||||
Common Equity, 2 Yr. CAGR % | 74 | 97.08 | 25 | 2.59 | 3.89 | |||||
Tangible Book Value, 2 Yr. CAGR % | 75.84 | 98.51 | 25.03 | 2.56 | 3.82 | |||||
Cash From Operations, 2 Yr. CAGR % | 7.09 | -70.7 | 19.7 | 385.56 | 3.95 | |||||
Capital Expenditures, 2 Yr. CAGR % | 9.35 | 36.82 | 0.55 | 39.86 | 33.24 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 25.64 | 163.81 | -27.51 | -79.9 | 69.35 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 21.23 | 174.57 | -22.52 | -98.84 | 62.5 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 23.56 | 41.22 | 34.47 | 40.55 | 14.96 | |||||
Gross Profit, 3 Yr. CAGR % | -22.98 | -22.91 | 26.22 | 259.58 | 84.6 | |||||
EBITDA, 3 Yr. CAGR % | 65.84 | 80.18 | 27.04 | -3.44 | -9.37 | |||||
EBITA, 3 Yr. CAGR % | 72.96 | 85.17 | 27.47 | -5.09 | -11.35 | |||||
EBIT, 3 Yr. CAGR % | 72.96 | 85.17 | 27.47 | -5.09 | -11.35 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 69.29 | 100.96 | 32.16 | -8.02 | -14.7 | |||||
Net Income, 3 Yr. CAGR % | 69.29 | 100.96 | 32.16 | -8.02 | -14.7 | |||||
Normalized Net Income, 3 Yr. CAGR % | 82.62 | 97.09 | 26 | -7.84 | -14.84 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 64.29 | 88.6 | 23.85 | -13.27 | -16.5 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 4.5 | 2.34 | 1.95 | 18.05 | 26.14 | |||||
Accounts Receivable, 3 Yr. CAGR % | 41.47 | 81.06 | 17.78 | 73.18 | 67.63 | |||||
Total Assets, 3 Yr. CAGR % | 48.65 | 44.76 | 38.73 | 17.16 | 10.8 | |||||
Common Equity, 3 Yr. CAGR % | 59.96 | 66.22 | 58.75 | 16.88 | 3.6 | |||||
Tangible Book Value, 3 Yr. CAGR % | 61.47 | 67.31 | 59.62 | 16.8 | 3.61 | |||||
Cash From Operations, 3 Yr. CAGR % | 16.9 | -58.48 | 25.37 | 13.74 | 191.67 | |||||
Capital Expenditures, 3 Yr. CAGR % | 8.32 | 17.87 | 11.38 | 38.9 | 9.42 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -15.64 | 46.02 | 37.24 | -61.48 | 2.13 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -16.1 | 42.78 | 47.56 | -94.27 | 4.44 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 27.84 | 39.43 | 33.18 | 30.08 | 26.48 | |||||
Gross Profit, 5 Yr. CAGR % | -7.75 | -6.12 | 24.21 | 24.46 | 17.47 | |||||
EBITDA, 5 Yr. CAGR % | 44.6 | 57.61 | 33.66 | 40.11 | 15.98 | |||||
EBITA, 5 Yr. CAGR % | 48.47 | 61.07 | 36.09 | 41.51 | 15.95 | |||||
EBIT, 5 Yr. CAGR % | 48.47 | 61.07 | 36.09 | 41.51 | 15.95 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 43.31 | 54.57 | 29.45 | 45.81 | 19.23 | |||||
Net Income, 5 Yr. CAGR % | 43.31 | 54.57 | 29.45 | 45.81 | 19.23 | |||||
Normalized Net Income, 5 Yr. CAGR % | 50.16 | 63.91 | 37.01 | 44.02 | 15.83 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 35.06 | 46.45 | 22.79 | 38.54 | 14.66 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.06 | 4.75 | 2.19 | 14.05 | 14.75 | |||||
Accounts Receivable, 5 Yr. CAGR % | 21.13 | 41.37 | 54.93 | 72.69 | 37.42 | |||||
Total Assets, 5 Yr. CAGR % | 45.34 | 44.17 | 36.77 | 29.09 | 27.67 | |||||
Common Equity, 5 Yr. CAGR % | 42.45 | 44.08 | 44.94 | 37.04 | 33.99 | |||||
Tangible Book Value, 5 Yr. CAGR % | 43.3 | 44.78 | 45.77 | 37.56 | 34.39 | |||||
Cash From Operations, 5 Yr. CAGR % | 47.95 | -29.6 | 18.01 | 11.03 | 16.32 | |||||
Capital Expenditures, 5 Yr. CAGR % | 13.52 | 10.39 | 5.14 | 26.22 | 19.65 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 56.03 | 27.69 | -15.15 | -33.94 | 49.28 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 54.47 | 26.93 | -13 | -79.2 | 53.37 |
Select your edition
All financial news and data tailored to specific country editions
















